About Congenital alpha2-antiplasmin deficiency
Congenital alpha2-antiplasmin deficiency is a rare disease catalogued by Orphanet (ORPHA:79). It is associated with the SERPINF2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Congenital alpha2-antiplasmin deficiency trials.
Search ClinicalTrials.gov for "Congenital alpha2-antiplasmin deficiency" or filter by Orphanet code ORPHA:79 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Congenital alpha2-antiplasmin deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Congenital alpha2-antiplasmin deficiency. Updated daily.